Pam McKay

5.3k total citations
77 papers, 1.4k citations indexed

About

Pam McKay is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Pam McKay has authored 77 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pathology and Forensic Medicine, 27 papers in Oncology and 23 papers in Genetics. Recurrent topics in Pam McKay's work include Lymphoma Diagnosis and Treatment (50 papers), CNS Lymphoma Diagnosis and Treatment (18 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Pam McKay is often cited by papers focused on Lymphoma Diagnosis and Treatment (50 papers), CNS Lymphoma Diagnosis and Treatment (18 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Pam McKay collaborates with scholars based in United Kingdom, United States and Australia. Pam McKay's co-authors include Kate Cwynarski, Mike Leach, Kim Linton, Barbara J. Bain, J. D. Williams, Gerald A. Coles, B. Hulme, Elizabeth A. Sanders, I. Cavill and E. McGregor and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Pam McKay

69 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pam McKay United Kingdom 21 763 524 443 389 355 77 1.4k
Rika Sakai Japan 24 581 0.8× 370 0.7× 526 1.2× 196 0.5× 465 1.3× 107 1.5k
Neta Goldschmidt Israel 23 514 0.7× 425 0.8× 331 0.7× 217 0.6× 355 1.0× 97 1.4k
R. Arranz Spain 21 717 0.9× 264 0.5× 861 1.9× 146 0.4× 429 1.2× 42 1.5k
Christoph Losem Germany 16 1.4k 1.8× 898 1.7× 1.1k 2.4× 237 0.6× 188 0.5× 46 1.9k
R. E. Marcus United Kingdom 18 1.1k 1.4× 640 1.2× 979 2.2× 223 0.6× 514 1.4× 47 1.9k
Daniel Espinouse France 19 584 0.8× 356 0.7× 590 1.3× 135 0.3× 410 1.2× 43 1.3k
Burhan Ferhanoğlu Türkiye 14 505 0.7× 262 0.5× 453 1.0× 118 0.3× 212 0.6× 78 1.1k
Delvyn C. Case United States 17 511 0.7× 404 0.8× 538 1.2× 161 0.4× 666 1.9× 42 1.4k
Carlos Chiattone Brazil 22 307 0.4× 503 1.0× 278 0.6× 81 0.2× 551 1.6× 99 1.1k
Sung Hwa Bae South Korea 19 291 0.4× 155 0.3× 468 1.1× 90 0.2× 382 1.1× 101 1.2k

Countries citing papers authored by Pam McKay

Since Specialization
Citations

This map shows the geographic impact of Pam McKay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pam McKay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pam McKay more than expected).

Fields of papers citing papers by Pam McKay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pam McKay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pam McKay. The network helps show where Pam McKay may publish in the future.

Co-authorship network of co-authors of Pam McKay

This figure shows the co-authorship network connecting the top 25 collaborators of Pam McKay. A scholar is included among the top collaborators of Pam McKay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pam McKay. Pam McKay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Catherine, Mandeep S. Sagoo, Edward Pringle, et al.. (2025). An international real‐world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators. British Journal of Haematology. 207(1). 123–131.
2.
3.
Chaganti, Sridhar, Christopher P. Fox, Cathy Burton, et al.. (2025). Management of relapsed or refractory large B‐cell lymphoma: A British Society for Haematology Guideline. British Journal of Haematology. 206(6). 1593–1603. 2 indexed citations
4.
Henderson, Alasdair, J. Andrew McClure, Balaji Venugopal, et al.. (2024). Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patients. Clinical Science. 139(1). 29–41.
5.
6.
Fox, Christopher P., Sridhar Chaganti, Graham McIlroy, et al.. (2024). The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline. British Journal of Haematology. 204(4). 1178–1192. 8 indexed citations
7.
Wilson, Matthew R., Emma Haynes, E. Robertson, et al.. (2023). ‘ACOPP’ chemotherapy for older and less fit patients with Hodgkin lymphoma—a multicentre, retrospective study. Hematological Oncology. 41(S2). 357–358.
8.
9.
Morschhauser, Franck, Hervé Tilly, Aristeidis Chaidos, et al.. (2019). Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor, in Patients with Relapsed or Refractory Follicular Lymphoma. Blood. 134(Supplement_1). 123–123. 29 indexed citations
10.
Radford, John, Pam McKay, Ram Malladi, et al.. (2017). Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation. Bone Marrow Transplantation. 52(3). 452–454. 3 indexed citations
11.
Chaganti, Sridhar, Tim Illidge, Sally F. Barrington, et al.. (2016). Guidelines for the management of diffuse large B‐cell lymphoma. British Journal of Haematology. 174(1). 43–56. 113 indexed citations
12.
McKay, Pam, Mike Leach, Robert M. Jackson, Gordon Cook, & Simon Rule. (2012). Guidelines for the investigation and management of mantle cell lymphoma. British Journal of Haematology. 159(4). 405–426. 51 indexed citations
13.
14.
Leach, Mike, et al.. (2009). Possible significance of cup‐like blasts in acute myeloid leukaemia. British Journal of Haematology. 148(2). 182–182. 5 indexed citations
15.
McKay, Pam, et al.. (2008). Discriminant analysis of macrocytic red cells. Clinical & Laboratory Haematology. 16(3). 225–234. 1 indexed citations
16.
McKay, Pam, et al.. (2008). CD5 - T lymphocytes in renal transplant recipients. Clinical & Laboratory Haematology. 13(4). 335–340. 1 indexed citations
17.
Goodlad, John R., A S Krajewski, Paul Batstone, et al.. (2003). Primary Cutaneous Diffuse Large B-cell Lymphoma. The American Journal of Surgical Pathology. 27(12). 1538–1545. 63 indexed citations
18.
Goodlad, John R., A S Krajewski, Paul Batstone, et al.. (2002). Primary Cutaneous Follicular Lymphoma. The American Journal of Surgical Pathology. 26(6). 733–741. 70 indexed citations
19.
McKay, Pam, S. Cameron, Alan K. Burnett, et al.. (1996). Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation.. PubMed. 17(1). 63–6. 96 indexed citations
20.
McKay, Pam, et al.. (1993). Should Hyposplenic Patients Receive Prophylaxis against Bacterial Infection?. Scottish Medical Journal. 38(2). 51–52. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rika Sakai Breakdown of academic impact, for papers by Neta Goldschmidt Breakdown of academic impact, for papers by R. Arranz Breakdown of academic impact, for papers by Christoph Losem Breakdown of academic impact, for papers by R. E. Marcus Breakdown of academic impact, for papers by Daniel Espinouse Breakdown of academic impact, for papers by Burhan Ferhanoğlu Breakdown of academic impact, for papers by Delvyn C. Case Breakdown of academic impact, for papers by Carlos Chiattone Breakdown of academic impact, for papers by Sung Hwa Bae
Rankless by CCL
2026